A5020803721- Vaccine Coverage and Hesitancy
- Influenza Virus Research Studies
- Respiratory viral infections research
- Viral gastroenteritis research and epidemiology
- Pneumonia and Respiratory Infections
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Genital Health and Disease
- Bacterial Infections and Vaccines
- SARS-CoV-2 and COVID-19 Research
- Hepatitis Viruses Studies and Epidemiology
- Adolescent and Pediatric Healthcare
- Emergency and Acute Care Studies
- Child and Adolescent Health
- Viral Infections and Outbreaks Research
- Mobile Health and mHealth Applications
- Mental Health and Psychiatry
- Global Cancer Incidence and Screening
- Herpesvirus Infections and Treatments
- Pediatric Pain Management Techniques
- Health Literacy and Information Accessibility
- Humor Studies and Applications
- Lymphadenopathy Diagnosis and Analysis
- Cancer Risks and Factors
- Cardiovascular Conditions and Treatments
University of Washington
2015-2024
Seattle Children's Hospital
2016-2024
Washington State Department of Health
2022
Klinikum Chemnitz
2019
Ludwig-Maximilians-Universität München
2019
Columbia University
2011-2017
New York Hospital Queens
2013-2015
Seattle University
2015
Karolinska Institutet
2015
Morgan Stanley Children's Hospital
2013-2014
This statement updates the recommendations of American Academy Pediatrics for routine use influenza vaccine and antiviral medications in prevention treatment children during 2023–2024 season. A detailed review evidence supporting these is published accompanying technical report (www.pediatrics.org/cgi/doi/10.1542/peds.2023-063773). The recommends annual vaccination all without medical contraindications starting at 6 months age. Children are risk hospitalization death from influenza....
To determine whether provision of vaccine-health-literacy-promoting information in text message vaccine reminders improves receipt and timeliness the second dose influenza within a season for children need 2 doses.During 2012-2013 season, families eligible 6-month through 8-year-old were recruited at time their first vaccination from 3 community clinics New York City. Children (n = 660) randomly assigned to "educational" message, "conventional" "written reminder-only" arms. At enrollment,...
To determine whether infection, with associated eicosanoid release, is a main cause of respiratory disruption in neonates, by measuring levels prostaglandin E2 (PGE2) and its metabolite (PGEM) cerebrospinal fluid (CSF).Of 59 eligible infants, 25 preterm infants (mean gestational age, 28 ± 0.5 weeks) 22 full-term 40 from level 3 neonatal intensive care unit the general maternity ward were enrolled prospectively. Infants condition that can secondary apnea excluded. Cardiorespiratory...
This technical report accompanies the recommendations of American Academy Pediatrics for routine use influenza vaccine and antiviral medications in prevention treatment children during 2023–2024 season. The rationale recommendation annual vaccination all without medical contraindications starting at 6 months age is provided. Influenza an important strategy protecting broader community against influenza. summarizes recent seasons, morbidity mortality children, effectiveness, coverage,...
Preterm infants are at increased risk for vaccine-preventable infections and associated complications. Limited studies describe timely vaccination of these vulnerable infants.This retrospective cohort study included Washington State with birth hospitalizations an urban academic medical center between 2008 2013. Demographic, clinical, visit data from electronic health records were linked to vaccine the Immunization Information System. Completion recommended 7-vaccine series by 19 months age...
OBJECTIVE: Live vaccines are generally contraindicated in patients with DiGeorge syndrome (DGS), a congenital disorder characterized by cellular immune deficiency. Vaccine utilization and safety this population not well described. This study examined vaccination patterns adverse events following live immunization (AEFLI) these individuals. METHODS: A multicenter retrospective cohort was conducted subjects DGS confirmed fluorescence situ hybridization assay (chromosome 22q11.2 microdeletion)....
To determine the impact of a vaccination reminder in an electronic health record supplemented with data from immunization information system (IIS).A noninterruptive influenza reminder, based on real-time query hospital and city IIS, was used at 4 urban, academically affiliated clinics serving low-income population. Using randomized cluster-crossover design, each study site had "on" "off" period during fall winter 2011-2012. Influenza clinic visit assessed for 6-month to 17-year-old patients....
OBJECTIVES: Parents frequently decline the influenza vaccine for their child during hospitalization. In this study, we aimed to assess role of hesitancy in these declinations. METHODS: This cross-sectional survey study was conducted among English-speaking parents vaccine-eligible children who were hospitalized between October 2014 and April 2015. Between July 2015 September 2015, recruited via mail complete validated Parent Attitudes about Childhood Vaccines (PACV) (modified vaccination)....
This statement updates the recommendations of American Academy Pediatrics for routine use influenza vaccines and antiviral medications in prevention treatment children during 2024–2025 season. A detailed review evidence supporting these is published accompanying technical report (www.pediatrics.org/cgi/doi/10.1542/peds.2024-068508). The recommends annual vaccination all without medical contraindications starting at 6 months age. Children are risk hospitalization death from influenza....
This study evaluated the impact of health system-based outreach and reminders on human papillomavirus (HPV) vaccine series initiation completion. Parents 10 to 12 year olds (n = 1805) were randomized receive either (1) an letter brochure recommending HPV vaccination followed by automated or (2) usual care. We interviewed a subset 50 parents assess program acceptability. Outcomes during period on-time Rates (July 2015 August 2016) similar between intervention control groups, but within 120...
<h3>Importance</h3> The quadrivalent human papillomavirus (HPV) vaccine was licensed for use in 9- through 26-year-old females 2006. Postlicensure studies Australia, Denmark, and Canada have demonstrated effectiveness against abnormal cervical cytology results. However, there are limited data describing postlicensure the United States, particularly among minority at higher risk HPV infection cancer. <h3>Objective</h3> To examine effect of vaccination on results females. <h3>Design, Setting,...
BACKGROUND: Infants born prematurely or with underlying conditions are at increased risk of severe rotavirus disease and associated complications. Given the theoretical nosocomial transmission vaccine-type rotavirus, vaccination is recommended for infants after discharge from neonatal care settings. Because first dose should be administered by 104 days age, some may age-ineligible if delayed until discharge. METHODS: This prospective cohort included admitted to an urban academic medical...